000 | 01810ngm a2200349 a 4500 | ||
---|---|---|---|
001 | HST1358_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 080121s2007 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1358 _bHenry Stewart Talks |
035 | _a(UkLoHST)599 | ||
035 | _a(UkLU-K)AC000391067 | ||
040 |
_aUkLU-K _beng _cUkLU-K |
||
100 | 1 |
_aIsaacs, John D. _4spk |
|
245 | 1 | 0 |
_aMonoclonal antibodies in the management of rheumatoid arthritis _h[electronic resource] / _cJohn D. Isaacs. |
260 |
_aLondon : _bHenry Stewart Talks, _c2007. |
||
300 |
_a1 online resource (1 streaming video file (42 min.) : _bcolor, sound). |
||
490 | 1 |
_aMonoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Background to rheumatoid arthritis -- Rheumatoid arthritis pathogenesis -- Aims of therapy in rheumatoid arthritis -- Targeting T-cells with depleting monoclonal antibodies -- Non-depleting therapies that target T-cells -- Targeting B-cells in rheumatoid arthritis -- Co-stimulation blockade -- Targeting the interleukin-6 receptor. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 2 |
_aAntibodies, Monoclonal _xtherapeutic use. |
|
650 | 2 |
_aArthritis, Rheumatoid _xtherapy. |
|
650 | 2 | _aArthritis, Rheumatoid. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pMonoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/599/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/30/ _3Series |
999 |
_c78007 _d78007 |